Amendola, Caroline R.
Mahaffey, James P.
Parker, Seth J.
Ahearn, Ian M.
Chen, Wei-Ching
Zhou, Mo
Court, Helen
Shi, Jie
Mendoza, Sebastian L.
Morten, Michael J.
Rothenberg, Eli
Gottlieb, Eyal
Wadghiri, Youssef Z.
Possemato, Richard
Hubbard, Stevan R.
Balmain, Allan
Kimmelman, Alec C.
Philips, Mark R.
Article History
Received: 10 August 2018
Accepted: 23 October 2019
First Online: 11 December 2019
Competing interests
: A.C.K. has financial interests in Vescor Therapeutics. A.C.K. is an inventor on patents that pertain to KRAS-regulated metabolic pathways, redox control pathways in pancreatic cancer, targeting GOT1 as therapeutic approach and the autophagic control of iron metabolism. A.C.K. is on the Scientific Advisory Board of Rafael Pharmaceuticals and has been a consultant for Diciphera Pharmaceuticals.